Patent details

301207 Product Name: tezepelumab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301207
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2205635
Status:
SPC granted but not yet in force
Application number:
301207
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/22/1677
Marketing Authorization Type:
EEA
Marketing Authorization Date:
20/09/2022
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
12/12/2022
First Marketing Authorization date:
20/09/2022
Grant date:
02/02/2023
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
16/12/2022
SPC/SPC Extension Expiration Date:
08/09/2033
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
12/12/2022
 
 

 

Name:
AMGEN INC.
Address:
One Amgen Center Drive, THOUSAND OAKS, CA 91320, United States of America (US)

Agent

Name:
J.M.H. Duyver lic.
From:
16/12/2022
Address:
Gevers Patents Holidaystraat 5, B-1831, Diegem, Belgium (BE)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
06/23
Publication date:
08/02/2023
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
51/22
Publication date:
21/12/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
30/09/2028
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
02/02/2023 Outgoing Correspondence Decision grant 1 PDF /3/2/7/3/4/0800843723/docs/301207_8_529268l504a.pdf
02/02/2023 Certificate Certificate 1 PDF /3/2/7/3/4/0800843723/docs/301207_9_spcmedcertificate20230202105332537.pdf
20/12/2022 Outgoing Correspondence Confirmation receipt request 1 PDF /3/2/7/3/4/0800843723/docs/301207_7_521228l174.pdf
12/12/2022 SPC Documents Annex SPC 14 PDF /3/2/7/3/4/0800843723/docs/301207_0_supplprotectioncertificate20221216094838872.pdf
12/12/2022 SPC Documents Accompanying letter SPC 6 PDF /3/2/7/3/4/0800843723/docs/301207_1_supplprotectioncertificate20221216094930415.pdf
12/12/2022 SPC Documents Summary of the characteristics of the product 14 PDF /3/2/7/3/4/0800843723/docs/301207_2_supplprotectioncertificate20221216095245707.pdf
12/12/2022 SPC Documents Marketing Authorization SPC 3 PDF /3/2/7/3/4/0800843723/docs/301207_3_supplprotectioncertificate20221216095327285.pdf
12/12/2022 SPC Documents Annex SPC 17 PDF /3/2/7/3/4/0800843723/docs/301207_4_supplprotectioncertificate20221216095245776.pdf
12/12/2022 SPC Documents Annex SPC 2 PDF /3/2/7/3/4/0800843723/docs/301207_5_supplprotectioncertificate20221216095245742.pdf
12/12/2022 Application Form First filed application form 3 PDF /3/2/7/3/4/0800843723/docs/301207_6_applicationform20221219043921917.pdf